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Abstract: 
Raman spectroscopy is a branch of vibration spectroscopy which is capable of probing the chemical 
composition of materials. Recent advances in Raman microscopy have added significantly to the range 
of applications which now extend from medical diagnostics to exploring interfaces between biological 
organisms and nanomaterials. In this review, Raman is introduced in a general context, highlighting 
some of the areas in which the technique has found success in the past, as well as some of the potential 
benefits it offers over other analytical modalities. The subset of Raman techniques which specifically 
probe the nanoscale, namely Surface Enhanced and Tip Enhanced Raman Spectroscopy, will be 
described and specific applications relevant to nanomedical applications will be reviewed. Progress in 
the use of traditional label-free Raman applied to investigation of nanoscale interactions will be 
described, and recent developments in Coherent Anti-Stokes Raman Scattering will be explored, 
particularly applications to biomedical and nanomedical fields. 
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Introduction 
 
Nanomedicine can be defined as the medical applications of nanotechnology[1], ranging from the use of 
nanomaterials in regenerative medicine, drug delivery strategies, medical diagnostics and therapeutics 
and including potential negative impacts of nanomaterials to human health, commonly encompassed 
under the term Nanotoxicology. In the context of this review article, nanomedicine is viewed from the 
perspective of how Raman spectroscopy (and its variants) can be used in the assessment of the 
beneficial as well as the potential negative impacts of Nanomaterials on human health. Nanomaterials 
have already found uses in a wide range of applications, including anti-microbial paint coatings[2], 
textile finishing[3], and novel applications in the electronics industry[4]. Notably, biomedical 
applications are rapidly emerging, ranging from nanoparticle coated stents for angioplasty[5], contrast 
agents for diagnostic imaging[6,7] and also potential drug and gene delivery vehicles[8–10]. These 
applications are largely dependent on the particular characteristics which nanomaterials and 
nanoparticles possess.  These include properties such as increased surface to mass ratio which in turn 
results in an increase in surface reactivity, while novel optical properties associated with some classes of 
nanoparticles are important for applications in theranostic imaging and subsequent monitoring of drug 
delivery. However, whilst these technologies show promise, it is important to be able to visualise how 
the materials behave in situ, and particularly in the biological context, to be able to characterise their 
interactions and toxicological effects, be they in-vitro or in-vivo. While it has been highlighted that 
comprehensive characterisation of the physico-chemical properties of nanoparticles is imperative, 
changes to these properties, such as aggregation state and effective surface chemistry, can play a critical 
role in their modes of interaction and action [11]. Equally, to understand the modes of action and 
optimise efficacies, monitoring and understanding changes to the biological environment is critical, not 
only on a cellular level but also when considering the systemic responses. 
Considering the system as a whole, one must be able to track a particle or material from initial 
exposure or administration through to the site of action and on to assimilation, degradation or 
excretion. At each step in this process, one must be able to access and visualise the efficacy by which the 
particles can overcome certain barriers to successful administration. These can vary from the route of 
exposure, assessing whether the particle causes toxicity, particle retention (e.g. via the enhanced 
permeability and retention (EPR) effect), or removal for circulation via uptake by the reticuloendothelial 
system (RES), accumulation of the nanoparticles over time, non-specific interactions, the efficacy with 
which the particle reaches its desired location etc.. 
Ideally, what is required is a method which can successfully characterise these processes, firstly 
in fundamental in vitro cytological and ex-vivo histological studies and ultimately in more realistic in-vivo 
applications. This method should be capable of identifying the particle or material of interest while 
simultaneously being able to access the surrounding environment while measuring the efficacy of the 
probe or nanocarrier and/or the physiological response of the organism.   
There exists a large range of analytical methods which can be used in the classification and 
characterisation of nanomaterials. These include scanning and transmission electron microscopy (SEM 
and TEM), atomic force microscopy (AFM), other label free optical methods such as differential 
interference contrast (DIC) and dark field microscopy and fluorescent microscopy methods based on 
intrinsic nanoparticle or external label fluorescence, to name but a few. However, these methods are 
not without certain drawbacks which limit to some extent their applicability and effectiveness. 
Firstly, both AFM and SEM can be considered as primarily surface sensitive techniques, while, 
when TEM is coupled with serial sectioning and ultra-microtomy, it has been used for 3D reconstructions 
and tomography[12,13]. However, these processes are time consuming, costly and laborious. In 
addition, EM requires a particle to have contrasting electron density compared to its environment to 
allow for a particle to be visualised, which renders it ineffective for many “softer” polymeric 
nanoparticles.  EM does not allow live cells to be imaged and, as it requires extensive sample processing, 
it provides only a limited scope for rapid or routine investigation of nanomaterials in-vitro. What EM and 
AFM do provide is the capability of imaging beyond the optical diffraction limit.  More recently 
developed optical based methods, so-called super resolution microscopy, have become available that 
allow for imaging beyond this limit [14–16]. However, their use has been limited in the field of 
nanomedical sciences as of yet.  
In contrast, standard fluorescent based microscopy has been used extensively in nanoparticle 
studies[16–19]. Confocal Laser Scanning (fluorescence) Microscopy (CLSM) has become a standard in 
the toolbox of techniques for in vitro cytommetry [21]. Although the technique is limited in resolution to 
hundreds of nanometers, it can potentially detect fluorescence emission from, and therefore the 
location of, individual nanoparticles. Penetration depths in vivo can be extended through two photon 
excitation techniques and/or NIR fluorophores [22,23]. In the visible region, a range of fluorescent 
assays and labels are commercially available to probe a range of physiological processes in vitro, such as 
lyso and mitotracker used for labelling lysosomes and mitochondria [101] Intrinsically fluorescent 
nanoparticles such as inorganic semiconductor quantum dots have been developed for similar 
applications [102] and surface functionalisation of these types of materials has contributed to 
understanding the dependence of uptake and intracellular trafficking on surface chemistry [24]. Many 
similar studies have been performed with fluorescently labelled nanoparticles [25,26] which are 
commercially available in a range of sizes and surface functionalities. However, not all nanoparticles can 
be easily fluorescently labelled. Furthermore, it is not clear that the transport mechanisms of smaller 
nanoparticles, fluorescently labelled with anionic moieties, are the same as their unlabelled 
counterparts [27]. Critically, there have been reports that labelled nanoparticles can release the dye into 
the surrounding biological environment, and so the distribution of fluorescence within the cell does not 
necessarily represent the presence or subcellular distribution of the nanoparticles[28–30]. Other label 
free optical microscopy techniques are also limited by the type of particle which can be visualised i.e. 
only metal based particles are effective for dark field and DIC microscopy [31].    
Raman spectroscopy has been proposed as a method for monitoring nanomaterials in biological 
systems, as it potentially provides a label free, non-invasive probe of the nanoparticle itself, the local 
environment and the physiology of the organism [32] . Over the past decade, Raman spectroscopy has 
been applied to a range of biomedical areas, including cancer diagnostics[33], toxicity studies[34], 
atherosclerosis[35] and investigation of skin[36,37].  Importantly, what Raman provides is not just a 
method for differentiation between a diseased and non-diseased state, it is based on characterisation of 
the (bio) chemical nature of a sample, based on the characteristic vibrations of the molecular bonds of 
the constituent components. Raman is a form of vibrational spectroscopy, which in itself is a subset of a 
more general umbrella term of spectroscopy. The vibrations are characteristic of the molecular 
structure and, in polyatomic molecules, give rise to a spectroscopic “fingerprint”. The spectrum of 
vibrational energies can thus be employed to characterise a molecular structure, or changes to it due to 
the local environment or external factors. The Raman spectrum is thus a truly label free signature of the 
nanoparticle. Vibrational energies typically fall in the mid Infrared (IR) region of the electromagnetic 
spectrum and are quite commonly probed using IR absorption spectroscopy. Raman in many ways can 
be viewed as a complementary technique to IR spectroscopy; whereas IR involves absorption of 
radiation, Raman is an inelastic scattering technique whereby the incident radiation couples with the 
vibrating polarisation of the molecule and thus generates or annihilates a vibration. For a vibration to be 
active in IR spectroscopy, a change in dipole is required, whereas to be Raman active, a change in 
polarisability is required. As a rule of thumb, vibrations of asymmetric, polar bonds tend to be strong in 
IR spectra, whereas Raman is particularly suitable as a probe of symmetric, nonpolar groups. 
Importantly, this results in the O-H bonds of water being strong absorbers in IR spectroscopy, whereas 
they are relatively weak Raman scatterers. This allows for samples to be investigated in an aqueous 
environment and thus the technique of Raman spectroscopy more readily lends itself to live cell in 
vitro[38] or in vivo[39] measurement. As the vibrational spectrum is measured as a frequency (or 
energy) shift from that of the incident radiation, Raman spectroscopy can be performed across the UV, 
visible or near infrared spectral regions, and thus can benefit from the technologies available and 
advances made for confocal optical microscopy.    
 A number of variants which are based around the physical principal of Raman spectroscopy 
exist. Spontaneous Raman can take the form of Stokes Raman scattering and anti-Stokes Raman 
scattering, the former resulting from the creation of a vibration in a material, characterised by a 
decrease in the incident photon energy (frequency), the latter from the annihilation of vibration, 
characterised by an increase in the incident photon energy. If the incident radiation is resonant with an 
electronic absorption of the analyte, the Raman signal can be resonantly enhanced by several orders of 
magnitude. The use of Resonant Raman Spectroscopy (RRS) in biomedical systems has been limited, 
however, due to associated photochemical degradation phenomena and the generation of fluorescence 
which can swamp the Raman signal of the overall sample.   
 Other variants of these two techniques with increased sensitivities for more molecularly 
specific characterisation have been developed. These include resonant Raman spectroscopy, coherent 
anti Stokes Raman spectroscopy (CARS), tip enhanced Raman spectroscopy (TERS) and surface enhanced 
Raman spectroscopy (SERS).  The majority of these techniques have been applied to nanomedical 
applications; however, two of these methods deal inherently with the nanoscale, namely TERS and SERS. 
Although Raman is fundamentally an optical technique and is thus similar to confocal optical 
microscopy, limited to spatial resolution of the order of hundreds of nanometres, nanometre resolution 
can be obtained through localised enhancement processes. This localised enhancement led to the initial 
interest in the prospect of the use of Raman spectroscopy to probe the specific environment of the 
nanoparticle.  
This article will outline the applications of the various Raman spectroscopy based technique in the broad 
area of Nanomedicine. As they are nano-specific, the use of SERS and TERS techniques will be presented 
initially, while the increasing interest in the use of truly label free spontaneous Raman and Coherent 
Anti-Stokes Raman Spectroscopy (CARS) in nanomedical applications will then be explored. In Raman 
spectroscopy, the sensitivity, spatial resolution and penetration depth and required scan rates depend 
on technique employed, resonance conditions and even the instrumental set-up (microscope objective, 
grating, laser power). In the respective section describing each modality, examples of the state of the art 
in nanomedical applications are provided. The future perspectives attempts to address routes beyond 
the current state of the art. A more detailed description of the historical origin and basic principles of 
the Raman scattering process can be found in numerous excellent text books[40–44] and review 
articles[45–47]. A comparison of Raman and IR spectroscopies for biomedical applications can be found 
in [48].  
 
 
SERS 
 The phenomenon of surface enhanced Raman spectroscopy was described as early as 1974 
[49,50], and is understood to arise from a localised increase in the coupling between the 
electromagnetic field of the incident radiation and the polarisation of the analyte in the presence of 
optically induced surface plasmons on a metal surface. Increases of Raman intensities as high as 10
10
 
have been reported [51], although the spatial range of enhancement is only of the order of tens of 
nanometers. The enhancement process can be achieved using a number of substrates including 
roughened metallic surfaces, structured metal arrays and specially imprinted surfaces.  
Notably, the SERS effect can be induced through the use of metallic nanoparticles and nano 
colloid aggregates. SERS is a direct enhancement of the Raman signal and in the case of nanoparticles 
this occurs in the immediately surrounding local vicinity. The true principal that governs SERS 
enhancement is not fully understood, although the effect has largely been attributed to an electronic 
enhancement due to local fields generated by surface plasmon resonances at the metal surface. 
Alternatively, the enhancement has been attributed to a charge transfer process between the analyte 
and the surface, although it is probable that the processes act in tandem[52]. The technique of SERS in a 
biomedical context is reviewed in greater detail in the following papers[53–55].   
 Nanoparticles and aggregates which are used for SERS enhancement typically consist of a 
metallic nanoparticle, most commonly gold and silver. Quite often, these particles are subsequently 
modified via surface functionalisation which can include targeting moieties designed for specific 
applications, especially as nanosensors. The particle may also be labelled with a Raman reporter moiety 
which allows for identification of the particle in the biological milieu. Using these particles, it has thus 
been possible to apply SERS to a number of biological scenarios, which include diagnostic studies in 
vitro, ex-vivo[56,57] and in-vivo[58,59] , novel bio assays[60–62] as well as cellular studies.  
SERS has been proposed as a method for understanding how nanomaterials behave in a cellular 
environment, important in the study of the fundamental interactions of nanoparticles in the context of 
toxicology, drug delivery or contrast agents for diagnostics.  In 2003, Kneipp et al. proposed that by 
using SERS it would be possible to probe the chemical nature of the subcellular environment and the 
intracellular distribution of biomolecules. This work was extended by incorporation of Raman reporters 
which allowed for localisation of the SERS probe within the cell, leading to chemical probing of sub 
cellular nanostructures[63–66]. For example, in 2010, the group showed how a SERS nanosensor was 
capable of investigating pH changes in a cell throughout the stages of the endocytic pathway of the 
nanoparticle probe. The study was based on changes in the pH of the local environment in different 
cellular organelles which can be monitored via changes in the pH sensitive nanoprobe over time[67].   
Other cellular studies have also investigated the possible use of SERS in the investigation of cell 
surface receptors associated with cancer. In one such study, Kong et al 2012 used organometallic SERS 
active nanoparticles which were targeted to live cells expressing the EGFR (epidermal growth factor 
receptor). The SERS nanoparticles were shown to be capable of specific targeting to the cell surface and 
offered increased sensitivity in comparison to other imaging modalities[68].  Figure 1 a-e, shows oral 
squamous cell carcinoma (OSCC) cells expressing the epidermal growth factor receptor (EGFR), c and e 
show the SERS image generated by CO at 2030cm
-1
 and protein at 1600cm
-1
 respectively. The targeting is 
verified in Figure 1 f – j in a non-EGFR expressing cell line SKOV3 (ovarian carcinoma) and in Figure 1 k-p 
by blockage of the EGFR using an EGFR antibody.  
 Figure 1 shows (a, f, k) the brightfield image, (b, g, l) the darkfield image of the nanoparticles, c, h, m) 
the SERS image of CO at 2030cm
-1
, (d, I, o) merged SERS and brightfield, and (e, j, p) the SERS image 
generated using the protein band at 1600cm
1
. a – e shows OSCC cells, f – g SKOV3 cells not expressing 
EGFR and k – p OSCC cells treated with anti-EGFR. Reproduced from [68] 
Another demonstrated application of SERS in is the analysis of human serum. Lin et al., in 2011, 
demonstrated the power of SERS coupled with multivariate analysis to distinguish in a non invasive way 
between patients previously diagnosed with colorectal cancer and control patients with 100% diagnostic 
sensitivity and specificity[69]. 
In-vivo SERS is also possible, and has been demonstrated as a potential labelling method for a 
number of applications. SERS has been used in-vivo to investigate how enhancement of the Raman 
signal can be used as a method for tumour detection. Qian et al. showed how EGFR targeting PEGylated 
gold nanoparticles labelled with a Raman reporter where capable of >200 times greater signal 
generation in the infrared compared to that of near infrared fluorescent quantum dots, which allowed 
for the possible identification of small tumours at penetration depths of ~ 1-2cm[58]. Other in-vivo 
applications of SERS have also been explored, including an in-vivo study of inflammation in mice[70], 
demonstrating improvements over fluorescent based methods. SERS has also been shown to be capable 
of single molecule detection in-vitro, a sensitivity which sets it apart from spontaneous Raman 
spectroscopy [71].    
More complex Raman based investigations have also taken advantage of the surface enhancement 
process. Techniques such as deep penetrating spatially offset Raman (SORS) have been combined with 
nanoparticle based SERS in SESORS[72,73]. In brief, in the SORS technique, introduced in a paper by 
Matousek et al, the Raman spectra are collected at positions spatially offset from the point of incidence 
of the probe laser beam. Rather than using microscopic objectives for delivery and collection, fibre 
probes are used. By moving the collection point away from the probe launch site, contributions from the 
surface Raman photons are diminished and those of Raman photons from deeper within the sample are 
increased. Using multivariate statistical methods, it is possible to reconstruct spectra from the different 
layers with a much greater depth of penetration than a traditional confocal microscopy setup[74]. 
Depth sensitivities of up to several millimeters are now achievable and examples of emerging 
applications include non-invasive diagnosis of bone disease, cancer and monitoring of glucose 
levels[75] SESORS uses this same principal, taking advantage of the surface enhancement of the Raman 
signal from metallic nanoparticles embedded within the sample. In a recent publication by Xie et al, 
SESORS was used to identify bisphosphonate-functionalized nanotags on bone through 20mm of porcine 
tissue[76]. This study highlights the increasing potential for in-vivo applications which SORS and SESORS 
may have, in the field of nanomedicine.      
SERS has enjoyed increasing popularity over the past decade, particularly since the emergence 
of as increasing range of nanoprobes. However, the uptake rates and mechanisms as well as the 
subsequent trafficking may be specific to the nanoparticle type, size and surface chemistry. Most SERS 
probes are specifically designed for a target application and so are labels themselves for the SERS signal. 
Furthermore, the molecular specificity of the surface enhancement process is not well understood. 
Therefore, a truly label free method for generic monitoring and characterising the cellular uptake and 
subcellular localisation of nanoparticles in general is still required. 
TERS another method for generating enhancement of the Raman signal. Like nanoparticle based 
SERS, this method is also based on probing of the inherent nanoscale environment of the sample in 
close proximity to a nanoprobe and will therefore be discussed.  
 
TERS  
Tip Enhanced Raman spectroscopy, or TERS, is a method which combines Raman spectroscopy and 
scanning probe microscopic techniques such as AFM.  TERS, like SERS, is a method to enhance the 
Raman signal and, in principle, the mechanism of enhancement is the same. Scanning probe tips have 
dimensions of the order of tens of nanometers or less, and when metal coated, surface plasmon 
resonances can be optically induced, similar to the case for metallic nanoparticles. In TERS, the 
topography of the nanoscale environment of samples can be probed by bringing the tip into close 
proximity with the area of the sample to be probed, but the Raman signal from the environment being 
probed by the tip is selectively enhanced by several orders of magnitude, swamping the spontaneous 
Raman from the remainder of the illuminated spot.  Therefore TERS is a method which allows for very 
small areas or even individual molecules to be probed in a label free manner. 
TERS has been used to investigate viral cell interaction[77], cytochrome-c states in isolated 
mitochondria[78], lipid and protein organisation in artificial cell membranes[79], as well as hemozoin 
crystal formation inside malaria infected red blood cells, as shown in Figure 2 [80]. Figure 2 A –C show 
AFM images of infected red blood cells, highlighting the hemozoin crystals inside the cellular vacuole in 
C. Figure 2 D shows the TERS spectrum from the edge of the crystal deposits showing characteristic 
peaks associated hemozoin and the profile is compared to the SERS and RRS spectra of β-hematin in F 
and G . This study highlights TERS as a nanoscale technique with can be used to probe very specific areas 
which may have implications in disease. In this instance, TERS provides a potential method to study the 
interaction of quinoline anti-malarial drugs which are believed to preferentially bind to the edge of 
hemozoin crystals.    
 Figure 2. TERS probing hemozoin crystal formation inside malaria infected red blood cells. A – C show 
AFM images of infected red blood cells. D shows the TERS spectrum for the edge of the hemozoin crystal 
deposit, E is the spectrum of the tip following retraction from the cell, F SERS spectrum of β-hematin, G 
resonance Raman (RR) spectrum of β-hematin. Reproduced from [80].  
 TERS has also been used in the investigation of the interaction between cells and nanoparticles. 
Alexander and Schultz (2012) were able to show the interaction of individual antibody conjugated 
nanoparticles and cell surface bio molecules using TERS, with a similar sensitivity to SERS[81].  
However, as TERS requires the use of AFM tips to enhance the signal, the method is restricted to 
being a surface classification technique and thus is of limited use for intracellular or indeed ex-vivo or in-
vivo tissue analysis. While surface enhanced methods provide promise in a number of nanomedical 
areas, there are some caveats associated with these methods. Firstly, the probe must be capable of 
generating a surface enhancement of the Raman signal; this is only applicable to certain types of gold 
and silver particles or coated tips, as well as nanoaggregates of these metals. Additionally, these 
techniques require a considerable expertise in synthetic chemistry and design of probes or tips for 
specific target applications. Furthermore, reproducibility of the enhancement is also a concern, in 
particular with TERS, were the reproducibility of the tip characteristics is important in gathering 
reproducible spectra. Therefore it is important to consider that, while surface enhanced methods have 
been shown to be capable of nanoscale accuracy, these methods are heavily reliant on specifically 
designed nanoparticle sensors or probes and tips which in some way dilutes the label free aspect which 
spontaneous Raman spectroscopy provides.     
Spontaneous Raman Spectroscopy 
To differentiate it from the numerous variants of Raman spectroscopy which have emerged over the 
past decades, including SERS and TERS, the originally named phenomenon of Raman spectroscopy is 
now frequently called spontaneous Raman spectroscopy. Spontaneous Raman spectroscopy has been 
used extensively over the past decades for a range of biomedical applications and is emerging as a viable 
alternative to gold standard protocols in medical diagnostics. Other uses include investigations in 
blood[82] and serum samples[83], investigations of human skin[36,37], cellular investigations[84–86], 
in-vivo[39] and ex-vivo[33] characterisations as well as studies of interaction of nanoparticles[34]. 
 Importantly, these applications using Raman spectroscopy rely on the use of data analytical 
methods which aid in the classification and understanding of the data which has been acquired. This 
may entail the use of chemometric methods to cluster a data set so that one can see a cell or tissue as a 
distribution of similar spectra in a map. Multivariate statistical methods can be employed for the 
separation of two different classes of spectra e.g. a diseased and non-diseased state. A full description 
of such analytical methods is beyond the scope of this review. However, it is important to highlight how 
Raman spectroscopy and multivariate data mining approaches are commonly used together to 
investigate the biochemical nature of samples.  Some good examples of where these statistical methods 
have been applied to Rama hyperspectral datasets can be found here[85,87,88]. 
 Despite the extensive development of Raman spectroscopy for biomedical applications and the 
specific use of SERS using nanoprobes, not many studies have explored the use of spontaneous Raman 
spectroscopy for nanomedical applications. Of the reports that exist, some have aimed to look at 
probing cells for a toxic response [34,89], others have aimed to look at how nanomaterials behave in a 
cellular environment[32,90] and some have looked at degradation patterns of potential nanoparticle 
drug carriers[91].  
 The potential of Raman spectroscopy as a toxicological screening method has been 
demonstrated for the case of carbon nanotubes and their effects on human cells in vitro. Kneif et al 
2010, showed how the cellular spectral signatures differed between control and exposed cells due to 
changes in specific Raman spectral peaks of the cell nuclei. This method provided a way of investigating 
the toxic response of cells to nanomaterials in a truly label free manner, compared to more typical dye 
based cytotoxicity testing. In addition to detecting differences in response due to nanoparticle exposure, 
it was also possible to statistically compare the dose dependent responses of the Raman signatures with 
other gold standard toxicity tests, demonstrating the potential of the technique as a quantitative high 
throughput screening assay[34].  
In a different type of study by Dorney et al 2012, the aim was to demonstrate the potential of 
Raman spectroscopy to visualise and investigate the interaction of polystyrene nanoparticles in cells. 
The purpose was to use these particles, which are often used as a standard in toxicity studies, as a 
model particle for further applications using Raman spectroscopy. In brief, the Raman spectroscopic 
signatures of the cells were mapped with a step size of 0.75µm over a region which contained both 
nuclear, perinuclear and cytoplasmic regions of the cell. Using a combination of K-means clustering and 
principal component analysis, it was possible to identify the localisation of the particles inside cells 
based on the intrinsic polystyrene signature and also to probe the chemical characteristics of the local 
subcellular environment[32]. A highlight of the results in shown in Figure 3 for cells incubated for 24hrs 
with polystyrene nanoparticles. The image in Figure 3 (i) shows the brightfield image (A) and the K-
means image constructed for the Raman hyper spectral dataset (B). The polystyrene nanoparticles are 
shown as green pixels in the image and the K-means average spectra are shown in Figure 3 (ii) A-D. The 
cluster associated with the green pixels clearly shows characteristic peaks associated with polystyrene 
when compared to a pure sample spectrum, Figure 3 (iii) A and B. The light blue and green clusters were 
then compared using Principal Components Analysis showing that the nanoparticles are located in lipid 
rich regions of the cell, which, by comparison with confocal fluorescence microscopy, was demonstrated 
to be the endoplasmic reticulum. 
 
 
Figure 3. Identification of intracellular distributions of polystyrene nanoparticles using Raman 
spectroscopy. (i) A shows the brightfield and 
cluster average spectra associated with the clusters i
the K-means cluster spectrum associated with polystyrene nanoparticles (A) 
spectrum of polystyrene (B). The Right panel
differentiating the green (nanoparticle) and light blue clusters (cytoplasm)
Component 1 (Bottom, A), suggesting the local environment surrounding th
Reproduced from [32]. 
Additionally, in a follow up paper by Keating et al 2012,
cross correlation analysis (SCCA) for localisation of 
(B) K-means image of the cell. (ii) shows the K
n the K-means image in the panel
compared 
s show a Principal Component Analysis 
, and the loading of Principal 
e nanoparticles is lipid rich. 
 the supervised approach 
nanoparticles was used on the same 
 
-means 
 above, (iii) shows 
with a pure 
scatter plot (top), 
of spectral 
spectral dataset. 
It was thus possible to identify all the regions within the cell that contained polystyrene nanoparticles, 
accounting for the misidentification of some clusters in the dataset that were apparent with K-means 
cluster analysis. The localisation of the nanoparticles to a lipid rich region of the cell is highlighted in 
Figure 4. Figure 4A and B show a pure polystyrene and lipid spectrum which have been cross correlated 
against the dataset to produce the pseudo colour images in Figure 4C, showing the lipid distribution, 
Figure 4D the distribution of polystyrene and the merge of the two in Figure 4E. This method provides a 
clear analytical approach for identification of nanomaterials and separation of different regions of the 
cell with a particular biochemical distribution[92].      
Figure 4.  Verification of identification of intracellular nanoparticles using spectral cross correlation 
analysis (SCCA). (A) and (B) show
phosphatidylethanolamine. (C) and 
distribution following SCCA with 3-
shown in E, indicating the particles in a lipid rich environment.  
 a pure spectrum of polystyrene nanoparticles and 3
(D) show the pseudo colour image of lipid and nanoparticle 
sn- phosphatidylethanolamine and polystyrene. Th
Adapted from [92].  
 
-sn- 
e merged image is 
Another recent study by Chernenko et al[93] aimed to investigate how different types of 
deuterated liposomal nanoparticles are distributed in cells.  More specifically, it aimed to investigate 
how different chemical compositions affected how the liposomes associated with the mitochondrion. 
Notable in this study is the use of deuterated liposomes to enhance the ability to differentiate liposomes 
from endogenous lipids in the cell, based on the fact that the C-D vibrational frequency is significantly 
down shifted from that of the C-H stretch of the very abundant intrinsic macromolecules of the cell. 
Another paper by the same group also looked at the degradation of polymeric nanoparticles over time 
in cells and concluded that poly lactic-co-glycolic acid (PLGA) and polycaprolactone (PCL) drug delivery 
systems are degraded and incorporated into the late endosomes of the Golgi system, based on spectral 
changes associated with the specific degradation patterns of the nanocarriers[91].   
 Spontaneous Raman spectroscopy has therefore already been demonstrated to be a chemically 
specific method for investigating nanoparticle interactions and also to probe the biochemical nature of 
cells.  Notably, a number of biochemical features can be accessed simultaneously without the need for 
fluorescence or other labelling methods, or for costly cytotoxicological assays. It should be noted, 
however, that, based on current technologies, spontaneous Raman is a relatively weak effect, thus 
highlighting the attention which surface enhanced techniques such as SERS and TERS have received. 
Relatively weak signals can be compensated for by longer acquisition times, with maximum 2D scan 
times of the order of 40-80 mins for a 50µm*50µm area with a step size of 500nm for cellular data[94]. 
However, these scan speeds are largely dependent on the required signal to noise ratio and the step size 
used in image acquisition. For these reasons real-time imaging has not been realised to date.  
Ultimately, for in vivo applications, penetration depth is also an important consideration. In 
Raman microscopy, sensitivities are optimised by choice of objective, providing optical spatial resolution 
but limited penetration depth (~1-50µm). As Raman spectroscopy is an optical technique, the 
penetration depth is largely determined by the choice of wavelength of the source laser, and optimally 
this can be chosen in the near infrared region where tissue has a transmission window. Absorption is 
largely governed by that of chromophores such as melanin (in skin) or haemoglobin across the visible, 
and by the overtones of OH vibrations in the near infra red regions. Scattering is an additional loss 
mechanism, but the development of Spatially Off-Set Raman Spectroscopy [75] using fibre probe rather 
than microscope objective delivery and collection optics, has exploited the fact that the signal from the 
deeper layers is scattered to a greater extent, to improve penetration depth sensitivities. CARS is 
another label free type of Raman scattering which can be used to probe bio and nanomedical scenarios 
and in recent years has seen a growth in applications in cells, tissues and in-vivo imaging. Using single 
wavelengths, imaging of large areas can be achieved at video rates.  
 
CARS 
Coherent anti-Stokes Raman spectroscopy (CARS) is a form of Raman spectroscopy whereby the anti-
Stokes shifted Raman signal is used to probe the molecular bonds within a sample. The coherent process 
takes advantage of a third order non-linear optical phenomenon by which three beams are used to 
probe the sample.  A fixed pump laser beam, a tunable probe beam are set at a frequency difference 
which is exactly equal to the frequency of a specific molecular vibration, resulting in the coherent build 
up of a scattered signal on the anti-Stokes side of the pump laser frequency [95,96]. The signal can be 
orders of magnitude larger than a spontaneous Raman signal. Thus, CARS can be used to rapidly 
generate images of a particular biochemical distribution and therefore can be used in the generation of 
video rate image sequences of cells and tissues. To generate a full spectroscopic signature, however, the 
pump beam has to be tuned such that the difference frequencies scan the vibrational spectrum, a 
process which can take considerable time, under current technological constraints. The nonlinear 
process is furthermore intensity dependent, requiring costly and notoriously temperamental short pulse 
lasers, whereas spontaneous Raman can be conducted with conventional steady state lasers.  
 In a biomedical context, the technique has been used to investigate a number of phenomena, 
also in conjunction with other methods such as immuno fluorescent labelling. Primarily, CARS has been 
used in the study of the C-H stretch region which is most commonly associated with lipids in living 
organisms. Examples include the use of CARS for the study of atherosclerotic lesions[97], intracellular 
trafficking[98], drug delivery[99], cancer metastasis[100], quantitative imaging of lipid distributions in 
living Caenorhabditis elegans[101] as well as imaging of the axonal myelin both in-vivo and ex-
vivo[102,103] CARS has also been used in the assessment of nanomaterials. Notably ,the technique 
has been used to study particle interaction in biological organisms, receptor mediated particle 
uptake[104] as well as the effects of particle size and coating on zebra fish embryos[105]. Moger et 
al[106] used CARS to investigate the interaction of metal oxide nanoparticles within the gills of rainbow 
trout, Onchrhynchus mykiss. They were able to show in a label free manner the translocation of TIO2 
particles across the epithelial membrane and into the capillaries in fish gill tissue. This is shown in figure 
5, which illustrates the forward (a) and epi-CARS images (b) of exposed fish gills. The merged image 
shows the localisation of the particles in the gill tissues, revealing particle clumps in green.   
 
Figure 5. CARS images of the TiO2 nanoparticle distribution in Onchrhynchus mykiss gills, (a) forward 
CARS image showing the nanoparticles, (b) epi-CARS image of the gill tissue and (c) merged forward and 
epi CARS image. Images reproduced from [106]. 
The method has also recently been used to investigate the mechanisms of oral uptake of 
Quaternary Ammonium Palmitoyl Glycol chitosan (GCPQ) nanoparticles. In this study, the particles were 
deuterated to shift the CH2 stretching vibration located at 2840cm
-1
 to a CD2
 
stretching vibration of 
2100cm
-1
. This allows for CARS to be carried out in the so called ‘silent region’ of the cell. Additionally 
second harmonic generation and two photon fluorescence were used to image the tissue containing 
nanoparticles.  In doing this, Garrett et al. were able to examine chitosan uptake and recirculation in the 
gut by being able to target the nanoparticles with cellular precision to the gastrointestinal tract, liver 
and gall bladder, providing novel insights in the role of enterocytes and bile recirculation regarding 
chitosan nanoparticles [99,107]. Figure 6 shows the identification of the deuterated nanoparticles in 
green (2100cm
-1
), which are highlighted by the arrows. Figure 6A and 6B show liver and stomach tissue 
respectively, with the C-D2 resonance being used to identify the deuterated nanoparticles (2100cm
-1
) in 
green and the C-H2 (2845cm
-1
) in red. Figure 6C shows a multimodal label free imaging approach 
combining CARS imaging (green), second harmonic generation (SHG) and two photon fluorescence (TPF) 
in imaging nanoparticle interaction with jejunum tissue. Figure 6D and 6E show the use of a combination 
of CARS and TPF to image the ileum and duodenum respectively, while Figure 6F shows a combination 
of CARS, SHG and TPF of the gall bladder. These approaches show not only how CARS can be used to 
probe nanoparticle interactions, but also highlight how multiple imaging approaches can be combined in 
multimodal approaches to give different types of information building towards a more complete picture.      
 Figure 6: Epi-CARS images with contrast derived from CD2 and CH2 resonances in GCPQ nanoparticles at 
2100 cm
−1
 (green) and 2845cm
−1
 (red) respectively. (A) Liver tissue. (B) Stomach tissue samples. (C) 
shows Jejunum tissue imaged with epi-CARS with contrast derived from the CD2 resonance (green), SHG 
contrast derived from collagen (blue) and TPF contrast derived from endogenous fluorophores. (D) 
Ileum tissue imaged with epi-CARS with contrast derived from the CD2 and TPF (red) (E) Duodenum 
imaged with epi-CARS with contrast derived from the CD2 and TPF (red). (F) Gall bladder imaged with 
epi-CARS with contrast derived from the CD2 resonance (green), SHG (blue) and TPF (red). Reproduced 
from [99]  
 
Surface enhancement can also be exploited in the CARS format. Surface enhanced CARS 
(SECARS) has been used in conjunction with nanoparticles and has been shown to be capable of 
achieving greater signal enhancement than that of SERS or CARS alone. For biomedical applications, it 
has also been used for the detection of single molecules of deoxyadenosine and deoxyguanosine 
monophosphate (dAMP and dGMP) [108] and has also been used in immuno-histochemistry 
studies[109]. 
 
Conclusions and Outlook 
This article has attempted to provide an overview of the current state of the art of the developing 
applications of Raman spectroscopic techniques in Nanomedicine. A recent review has dealt more 
broadly with the applications of these techniques in the investigation of the interaction of nanomaterials 
with complex biological systems [110]. The development of biomedical applications of vibrational 
spectroscopy, both Raman and IR, has been extremely active for the past two decades and more and the 
challenges to nanomedical applications are intrinsically linked, as indeed they are to those of the 
fundamental understanding of nanobio interactions in general. 
As a molecular specific tool, Raman spectroscopy can potentially aid significantly to the understanding 
of nanobio interactions in vitro. Even before interaction with the cell, it has been argued that the 
biological identity of the nanoparticle is determined by the surface coatings of the dispersion medium, 
the co-called protein corona [111]. While SERS active nanoparticles can be employed to probe this 
interaction acellularly, there is evidence that the nanoparticle medium interaction is very specific to the 
surface characteristics and size, and thus the use of truly label free spontaneous Raman spectroscopy 
may lead to broader insights. In this context, the increased sensitivity of TERS may be of significant 
benefit. SERS has however demonstrated that the surface coating can evolve significantly after 
endocytosis of the nanoparticle [110], and this is a critical consideration in the bioavailability of surface 
functionalities, including release of active ingredients, which have been specifically designed for 
nanomedical applications.  
As an confocal optical microscopic technique, Raman holds all the benefits of confocal 
fluorescence techniques, but has the potential advantage of being truly label free, adding the promise of 
reduced cost and sample processing requirements. SERS probes have demonstrated the potential to 
probe nanoparticle uptake, trafficking as well as the local environment, but these probes need to be 
specifically chemically tailored for the given application can so the technique cannot be considered to be 
truly label free. Spontaneous Raman spectroscopy is, on the other hand, an intrinsically weak 
phenomenon and cellular mapping is often a prolonged processes. Nevertheless, a number of cellular 
studies have been conducted which, although not specifically probing nanoparticles, may have 
implications in future nanomedical applications. For example, some studies have shown the application 
of Raman to drug delivery investigations [112,113] while other studies have identified sub cellular 
structures such as the mitochondrion as well as lipid rich regions which may be associated with the Golgi 
and endoplasmic reticulum [86]. Klein et al. used image registration and immuno fluorescence to verify 
the locations of cellular organelles and also as a means of extracting the spectra which were specifically 
associated with the organelle[114]. These studies could be extended to look at nanoparticle trafficking 
studies, colocalizing the particle to an organelle in a label free manner, without using fluorescently 
labelled nanoparticles or organelle stains. Although spontaneous Raman studies are commonly 
conducted on fixed cells, live cell spectral profiling has been demonstrated [37]. Image analysis is 
ultimately dependent on the reliability of multivariate chemometric techniques and simulated model 
systems can prove invaluable in validating their accuracy [81]. Increased acquisition rates can be 
achieved by systems custom designed for biological applications, and CARS potentially offers a route 
towards routine in vitro screening of intracellular nanobio interactions, although its ability to rapidly 
screen the full spectrum is currently limited by the (tuneable) laser source technologies and applications 
are thus restricted by the need to identify specific spectral marker bands. 
In terms of disease diagnostics, ex vivo applications of Raman spectroscopy have received much 
attention. For the range of Raman modalities, however, mapping of large areas of tissue biopsies also 
suffer from issues of weak signals (spontaneous), specifically targeted probes (SERS), surface sensitivity 
(TERS) or the need for specific spectral markers (CARS). As a chemically specific probe, however, Raman 
techniques are particularly suitable for analysis of biomarkers of disease in biological fluids [71,72] and 
this suitability is readily extended to applications in nanomedicine.  
Raman scattering is fundamentally an optical technique and in vivo applications are thus limited by the 
ability to access the area of interest. For dermal analysis, custom designed systems are commercially 
available which exploit the near infrared transmission window of skin, although, in a microscopic format, 
the penetration depth is further limited by the delivery optics, typically to some hundreds of microns. 
Advances in SORS have increased the depth resolution, and such technologies could prove invaluable 
tools for analysis of transdermal nanodrug delivery or environmental exposure to nanoparticles. As an 
optical technique, Raman spectroscopy readily lends itself to endoscopic probes [115], however, and 
recent advances in such in vivo probes may significantly impact on biomedical applications of Raman 
spectroscopy, including, inevitably Nanomedicine. 
Future Perspectives 
The field of nanotechnology is set to grow ever rapidly as new applications and avenues of research are 
explored over the coming decade. Crucially, characterisation and visualisation methods in a medical 
setting must develop in tandem, to access the applicability of such nanotechnology. Raman 
spectroscopy represents a method proven in the field of disease diagnostics and biomedical imaging and 
thus by extension holds the capability to progress the field of nanomedicine.  
Spontaneous Raman spectroscopy provides a versatile and truly label free method which has seen 
success in a number of different medical applications, most notably in disease diagnostics. Key enabling 
technological developments in this context include endoscopic and other in vivo probes. Relatively Low 
signal strengths currently limit the technique to small areas and/or long scan times, however, and 
continuing improvements in signal throughput and detector sensitivities are important.  EU Directives 
limiting the use of animal models will put increasing emphasis on the development of in vitro screening 
methods and Raman is a potential candidate for high content analysis of, for example, the efficacy and 
mode of action of novel chemotherapeutical agents of toxicants. The high optical resolutions obtainable 
make Raman particularly suitable for acellular or subcellular studies of nanobio interactions. As the 
sensitivity of the Raman technique is intimately linked with the multivariate statistical data analysis 
methods, the quantitative specificities of these methods must be established. This can only be done if 
the true result is known, and in this context the use of specifically constructed model datasets may 
provide a quantifiable insight into how far Raman spectroscopy can be pushed in both a medical and 
nanomedical context.  
SERS provides increased sentitivities to probe the nanoscale environment surrounding metallic 
nanoparticles. Although the technique is not truly label free, with the increased sensitivities achievable 
as well as the targeting potential of such probes, SERS may provide alternative imaging strategies for 
disease diagnostics in-vivo, as well as provide enhanced methods for the monitoring of human fluids 
such as serum and other metabolic excretions ex-vivo. SERS in-vitro may also prove a useful tool in 
probing the nature of the so called protein corona of nanoparticles in biological media and thus provide 
valuable insights into the surface behaviour of nanomaterials in a biological setting. Other enhancement 
methods such as TERS also provide novel insights into the nanoscale environment although they are 
limited by being mainly a molecular or surface specific technique.   
Coupling these advances in spontaneous and surface enhanced Raman with the development of SORS 
and SESORS, some of the shortcomings in signal generation and depth penetration of Raman 
spectroscopy in-vivo may be overcome. In addition to the development of endoscopic and needle based 
probes which will increase access to the point of interest, realistic applicable in-vivo Raman studies in 
nanomedicine may not be too far away. CARS provides a method which is capable of video rate scan 
speeds. However, as of yet the technique is not a spectroscopic imaging technique as it only allows for 
the probing of one particular wave number or vibrational marker at a time. The technique therefore 
requires a clearly identifiable biomarker for imaging, which may not be the case for all biomolecules.  A 
CARS system that could provide a spectrum of the finger print region of the sample with similar real 
time imaging capabilities would be ideal. Specifically for CARS to progress as a spectroscopic imaging 
modality, advances in laser technology such as rapidly tunable lasers will need to develop in tandem. 
These advances would then open a myriad of applications for CARS imaging along the lines of 
spontaneous Raman imaging.   
 
Executive Summary 
Raman Spectroscopy: Raman spectroscopy is a well established chemical analysis technique finding 
increasingly broader applications, particularly in biochemical analysis and disease diagnostics.  
Surface/Tip enhanced Raman Spectroscopy: The techniques of SERS and TERS specifically probe the 
nanoscale and, although TERS is a topical/surface technique, SERS probes have already been used 
extensively for in vitro and in vivo studies. SERS probes are normally chemically functionalised according 
to the specific target, and so the technique is arguably not truly label free. 
Spontaneous Raman Spectroscopy: As a truly label free technique, (spontaneous) Raman spectroscopy, 
coupled with multivariate analytical techniques potentially provides a probe of nanoparticles in 
cells/tissue, their nature of their local environment, and physiological changes. Unenhanced, the signals 
are however relatively weak, and large scale mapping can be time consuming. 
Coherent anti-Stokes Raman Spectroscopy: CARS is a nonlinear optical technique which is increasing in 
prominence for biomedical applications. Tuned to a specific vibrational frequency, it can scan large areas 
(cm
2
) at video rates. Currently, however, it is not a spectroscopic technique and does not avail of the full 
biochemical information available, but relies on the presence of a specific spectral marker.  
Outlook: The range of modalities of Raman spectroscopy potentially hold great promise for biomedical 
and nanomedical applications, although many technical challenges remain. 
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